Superior T-cell immunity in COVID vaccinated
A recent study published in the journal Public Library of Science (PLOS) ONE presented the T cell and humoral immune responses following severe acute respiratory syndrome coronavirus...
immunity
-
-
mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which harbors numerous mutations at the viral spike protein, evades host immunity by escaping...
-
Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19
In a recent study posted to the bioRxiv* pre-print server, researchers developed a highly pathogenic mouse-adapted (MA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain...
-
Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2
Even as the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic,...
-
Scientists show how T cells may help protect against severe COVID
In a recent study published in the Clinical Infectious Diseases journal, the researchers summarized the perspectives and observations on severe acute respiratory syndrome coronavirus 2...
-
A potential way for overcoming immunotherapy resistance in patients with mucosal melanomas
The development of the anti-cancer immunotherapy drugs called immune checkpoint inhibitors has improved treatment for many cancer patients, but patients with mucosal melanomas -; melanomas...
-
Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive
Authorities in Wuhan, China, reported a spate of atypical pneumonia cases on December 31, 2019. The disease was dubbed coronavirus disease 19 (COVID-19), caused by...
-
Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination
In a recent article posted to the medRxiv* preprint server, researchers assessed the factors influencing the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) antibodies...
-
Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England
The rapid and inexorable spread of the coronavirus disease 2019 (COVID-19) pandemic led to the intensive research effort to bring out safe and effective vaccines...
-
The challenges of Omicron
The coronavirus disease 2019 (COVID-19) pandemic broke out early in 2020, following the reporting of several cases of pneumonia caused by the severe acute respiratory...
-
The long-term impact of prior SARS-CoV-2 infection on immune responses after COVID-19 vaccination
Despite evidence relating effectiveness of the current crop of vaccines used against coronavirus disease 2019 (COVID-19) in clinical trials as well as post-marketing surveillance data,...
-
Prior COVID-19 protects against subsequent infections
In a recent study published in the Journal of American Medical Association (JAMA), researchers evaluated the duration and level of protection conferred by a coronavirus...